Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease
- 30 June 2012
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 33 (6), 1057-1066
- https://doi.org/10.1016/j.neurobiolaging.2010.09.013
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Nutrition in Brain Development and Aging: Role of Essential Fatty AcidsNutrition Reviews, 2008
- Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS‐LDAFEBS Letters, 2006
- Urinary polyamines and N-acetylated polyamines in four patients with Alzheimer's disease as their N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography–mass spectrometry in selected ion monitoring modeAnalytica Chimica Acta, 2006
- Docosahexaenoic acid and neurologic development in animalsJournal of the American Veterinary Medical Association, 2006
- Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseasesNeurobiology of Aging, 2005
- A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse ModelJournal of Neuroscience, 2005
- Vascular Basis of Alzheimer's PathogenesisAnnals of the New York Academy of Sciences, 2002
- Combining Genomics, Metabolome Analysis, and Biochemical Modelling to Understand Metabolic NetworksComparative and Functional Genomics, 2001
- Analysis of the core components of Alzheimer paired helical filaments A gas chromatography/mass spectrometry characterization of fatty acids, carbohydrates and long‐chain basesFEBS Letters, 1995
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984